Physician profile
Maury Hurst
NPI 1629032248
$4,213.85
in general payments reported to CMS, 2019-2025
17 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $532 · 2020: $1,063 · 2021: $1,025 · 2022: $819 · 2023: $417 · 2024: $247 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $677.48 | 2019-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $506.06 | 2019-2024 | Rybelsus, Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $454.11 | 2020-2023 | Xifaxan |
| Abbvie INC. | $416.71 | 2021-2025 | |
| Pfizer INC. | $382.60 | 2019-2024 | |
| Lilly USA, LLC | $305.82 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $286.07 | 2019-2025 | Jardiance |
| Allergan, INC. | $235.95 | 2019-2020 | |
| Amarin Pharma, INC. | $222.27 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $197.84 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $187.61 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $171.16 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $73.59 | 2019-2022 | |
| Angiodynamics, INC. | $36.00 | 2022 | |
| Exact Sciences Corporation | $23.91 | 2024 | Cologuard Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $18.56 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.11 | 2023 | Livalo, Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maury Hurst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.